NASDAQ:BBC

Bioshares Biotechnology Clinical Trials Fund ETF Predictions

Financial Services > Asset Management

Buy BBC

*Your capital is at risk

$53.04

-1.84 (-3.34%)

At Close: Jul 10, 2026

Currently predicting for Mon, 13 Jul 2026

BBC Live board

Community Bull/Bear

Target Next close

Join the BBC prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

BBC Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For BBC

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

BBC Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT BIOSHARES BIOTECHNOLOGY CLINICAL TRIALS FUND

The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the BioShares Biotechnology Clinical Trials Index. Under normal market conditions, the fund will invest not less than 80% of its total assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead ...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
SRPT $17.02	11.34%	Jun 29
NMRK $15.02	1.20%	Jun 24
NESR $25.07	14.16%	Jun 23
CAG $13.43	2.98%	Jun 23
GIB $66.69	0.555%	Jun 12

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by